1van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 1991, 254(5038): 1643-1647.
2Muscatelli F, Walker AP, De Plaen E, et al. Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci USA, 1995, 92(11): 4987-4991.
3Lucas S, De Smet C, Arden KC, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res, 1998, 58(4): 743-752.
4Kirkin AF, Dzhandzhugazyan KN, Zeuthen J. Cancer/testis antigens: structural and immunobiological properties. Cancer Invest,2002, 20(2): 222-236.
5Juretic A, Spagnoli GC, Schultz Thater E, et al. Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies. Lancet Oncol, 2003,4(2):104-109
6Eichmuller S, Usener D, Thiel D, et al. Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity. Int J Cancer, 2003, 20, 104(4):482-487.
7Kufer P, Zippelius A, Lutterbuse R, et al. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease. Cancer Res, 2002, 62 ( 1 ): 251-261.
8Li J, Yang Y, Fujie T, et al. Expression of the MAGE gene family in human gastric carcinoma. Anticancer Res, 1997, 17(5A) :3559-3563.
9Katano M, Nakamura M, Morisaki T, et al. Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease. J Surg Oncol, 1997, 64(3): 195-201.
10Dhodapkar MV, Osman K, Teruya Feldstein J, et al. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGEA4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.Cancer Immun, 2003, 23(3): 9.
